Uncovering disparities in access to popular treatments: insights from linked EHR and SDOH data


Explore how linked electronic health record (EHR) and social drivers of health (SDOH) data are accelerating the identification of health disparities for Type 2 diabetes, Alzheimer’s disease, and heart disease treatments.

Through research vignettes highlighting GLP-1s, lecanemab, and TAVR/SAVR procedures, experts from Truveta will demonstrate how complete, clean, and timely regulatory-grade EHR data is shedding light on inequities in therapy access and outcomes. The findings, which rely on linked, patient-level SDOH data, highlight noteworthy variability in treatment patterns based on race, ethnicity, income, familial support, urban/rural status, and more.

Your details

Subscribing to

Confirm sign-up

What you will learn:

  • Learn how clinical expert-led AI is unlocking data hidden within unstructured EHR and SDOH data to enable novel real-world research
  • Delve into recent studies highlighting trends in real-world use of popular treatments
  • Gain ideas for leveraging linked EHR and SDOH data to identify and address healthcare disparities
Speakers:

Ryan Ahern, MD
Co-founder and Chief Medical Officer, Truveta

 
Dr Ryan Ahern is Co-founder and Chief Medical Officer of Truveta, and has more than a decade of experience in healthcare data and clinical research. At Truveta, Ryan leads the Life Science Partner team, which focuses on developing new partnerships and ensuring those partners are successful in their research. He is currently a Clinical Assistant Professor of Medicine at the University of Washington School of Medicine and practices at Harborview Medical Center, Seattle’s large county hospital. Prior to this, he trained in internal medicine at the Massachusetts General Hospital and has served as a Clinical Assistant Professor of Medicine at Weill Cornell Medical Center and New York Presbyterian; attending physician at Massachusetts General Hospital; and instructor at Harvard Medical School.​​​​​​​

Tricia Rodriguez, PhD, MPH
Principal Applied Scientist, Truveta


Tricia Rodriguez, Principal Applied Scientist at Truveta, specializes in using real-world data (RWD) to study patient outcomes. With over a decade of experience in RWD, she's conducted research and published in a variety of disease areas, including diabetes, colorectal cancer, cystic fibrosis, HIV, and eating disorders. Tricia holds a PhD in Health Economics and Outcomes Research and a Master’s in Public Health, both from the University of Washington. Before Truveta, she held research positions at Verily Life Sciences and the University of Washington.

Moderator:

Laura Dormer

Editor, The Evidence Base
Editor in Chief, Journal of Comparative Effectiveness Research
Editorial Director, Becaris Publishing 

Share this webinar